Working… Menu

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00907179
Recruitment Status : Terminated (Widespread use firstline Pemetrexed; slow recruitment; funding withdrawn..)
First Posted : May 22, 2009
Last Update Posted : July 22, 2015
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015